The Problem with Fragmented Clinical Trial Technology
The clinical research industry has tolerated fragmented toolchains for decades: one vendor for electronic data capture, another for randomization, a third for medical coding, and separate contracts for e-signatures, RTSM, and regulatory reporting. Each integration point creates data mapping risk, validation gaps, and vendor lock-in that compounds with every protocol amendment.
When a monitor queries a data point that spans two systems, resolution requires coordination across vendors. When a protocol amendment changes a visit schedule, the EDC vendor, the RTSM vendor, and the coding vendor all need separate change orders. The result: 76% of protocols require amendments (averaging 3.3 each), and each Phase III amendment costs a median of $535,000 in direct costs — not counting the 260-day average implementation timeline.
AccuraTrials reduces this fragmentation. As a unified AI-native EDC platform, it allows you to:
- Reduce build times: One setup for EDC, RTSM, and coding.
- Minimize errors: Shared data models prevent integration mapping failures.
- Support inspection readiness: A single, immutable audit trail spans the entire platform.
Eight Modules, One Platform
Each module is fully integrated — data flows seamlessly without manual mapping or vendor coordination.
eCRF Builder & AI Parser
Upload a protocol PDF and get a complete eCRF draft in minutes. Refine with a visual drag-and-drop builder offering 50 field types, branching logic, and calculated fields.
AI Validation Engine
Describe edit checks in plain English. The AI proposes executable rules with four outcomes: Block Save, Auto-Query, Warning, or Conditional Required. You review and apply with one click.
Query Management
Auto-generated queries from failed validations, plus manual queries with attachments and conversation threads. Bulk operations, role-based routing, and escalation timers.
Randomization & RTSM
Stratified randomization with configurable factors, blinded study arms, an unblinding workflow, and integrated kit tracking and shipment management.
Medical Coding
Code adverse events and concomitant medications against MedDRA and WHODrug dictionaries with AI-assisted term matching and batch coding workflows — no separate coding vendor.
Source Data Verification
Monitor-facing SDV workflows with form-level and field-level verification, remote monitoring support, and verification audit logs that satisfy ICH E6(R2) requirements.
Data Locks & E-Signatures
Five-step lock workflow: readiness check, freeze, sign, lock, export. E-signatures require credential re-authentication and reason-for-signing, per 21 CFR Part 11.
Export & Regulatory Submission
Export to PDF, Excel, CSV, ODM XML, and tab-delimited formats. Dedicated regulatory export packages data with complete audit trails for FDA and EMA submissions.
What AccuraTrials Changes at Every Phase
Whatever phase you're running, the same operational pain shows up: slow builds, expensive amendments, and a vendor change order for every protocol tweak. Here's what changes for your team at each phase.
Phase I
Small cohorts (20–80 patients) but intensive safety monitoring and frequent protocol tweaks. Industry-wide, a substantial amendment takes a median 260 days to fully implement (Tufts CSDD 2024). On AccuraTrials, your team deploys the eCRF changes the same day — no vendor, no change order.
Phase II
100–300 patients across multiple sites, where 76% of protocols need at least one amendment (Tufts CSDD 2024). Implementing one costs a median $141K industry-wide (Getz et al., Tufts CSDD); AccuraTrials deploys the eCRF changes same-day in a visual editor.
Phase III
300–3,000+ patients across global sites, where a substantial amendment costs a median $535K to implement (Getz et al., Tufts CSDD) and every delayed build pushes your timeline. AccuraTrials removes the vendor change-order cycle from the eCRF side so your team stays on schedule.
Phase IV (Post-Market)
Ongoing safety surveillance across thousands of patients. Rapid protocol modifications required to capture emerging safety signals. AccuraTrials' self-service form editor and AI validation mean real-time study adjustments without vendor dependency.
Sources: Getz et al., Tufts CSDD 2024; Getz et al., "Cost of a Delay Day," 2024
Who Switches to AccuraTrials — and Why
Organizations migrate for three consistent reasons:
- Pharmaceutical Sponsors need real-time enrollment dashboards, protocol amendment agility, and audit-ready compliance controls. AccuraTrials reduces the multi-vendor coordination that delays submissions and inflates budgets.
- Contract Research Organizations manage multiple studies for multiple sponsors. AccuraTrials provides multi-tenant architecture with organization-level access controls and per-study permission isolation — all from a single platform.
- Academic Medical Centers need enterprise-grade compliance without enterprise pricing. AccuraTrials delivers 21 CFR Part 11 workflows, AI-powered study builds, and self-service operation for teams without dedicated EDC programmers.
- Biotech Startups need to move through Phase I and II without the overhead of multi-year EDC contracts. AccuraTrials goes live in days and charges based on actual study activity, not headcount.
Clinical Trial Software FAQ
What is the difference between EDC and clinical trial software?
EDC software handles electronic data capture: form design, data entry, validation, and export. Clinical solutions software is the broader platform that adds randomization, query management, medical coding, source data verification, e-signatures, and study administration. AccuraTrials provides both in a single, unified product.
Can AccuraTrials replace multiple clinical trial vendors?
In most cases, yes. AccuraTrials is a comprehensive clinical solutions software that covers EDC, randomization, RTSM, query management, medical coding, SDV, e-signatures, data locks, and regulatory export. For specialized needs like CTMS or safety databases, AccuraTrials integrates via REST API.
Does AccuraTrials support all trial phases?
Yes. Phase I and II benefit from rapid study setup and reduced build times. Phase III and IV benefit from multi-site management, stratified randomization, and enterprise-grade compliance controls that support inspection readiness.
How does AccuraTrials handle protocol amendments?
Amendments are handled visually: modify forms, add or remove fields, update validation rules, and activate the new version. Because every module shares the same data model, changes propagate same-day — reducing build times and avoiding vendor programming change orders.
Consolidate Your Clinical Trial Technology
See how one platform can replace your fragmented vendor stack — with a 30-minute demo tailored to your study type.
Request a Demo